Cargando…

RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer

BACKGROUND: The RNA-binding protein Musashi-2 (MSI2) has been implicated in the tumorigenesis and tumor progression of some human cancers. MSI2 has also been reported to suppress tumor epithelial-to-mesenchymal transition (EMT) progression in breast cancer, and low MSI2 expression is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ming, Li, An-qi, Zhou, Shu-ling, Lv, Hong, Wei, Ping, Yang, Wen-tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245804/ https://www.ncbi.nlm.nih.gov/pubmed/32448269 http://dx.doi.org/10.1186/s13046-020-01587-x

Ejemplares similares

Transformation of the intestinal epithelium by the MSI2 RNA binding protein
por: Wang, Shan, et al.
Publicado: (2015)

Knockout of RNA Binding Protein MSI2 Impairs Follicle Development in the Mouse Ovary: Characterization of MSI1 and MSI2 during Folliculogenesis
por: Sutherland, Jessie M., et al.
Publicado: (2015)

Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research
por: Yan, Shunchao, et al.
Publicado: (2023)

The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer
por: Melo, Carina Mucciolo, et al.
Publicado: (2021)

Msi RNA-binding proteins control reserve intestinal stem cell quiescence
por: Yousefi, Maryam, et al.
Publicado: (2016)

Identification of Five Cytotoxicity-Related Genes Involved in the Progression of Triple-Negative Breast Cancer
por: Zhang, Yan, et al.
Publicado: (2022)

RNA-Binding Protein MSI2 Binds to miR-301a-3p and Facilitates Its Distribution in Mitochondria of Endothelial Cells
por: Guo, Qian Qian, et al.
Publicado: (2021)

Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study
por: Tiron, Crina E., et al.
Publicado: (2021)

Triple negative breast cancer: Pitfalls and progress
por: Zagami, Paola, et al.
Publicado: (2022)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Research progress on immunotherapy in triple-negative breast cancer (Review)
por: Zhang, Xiaoxiao, et al.
Publicado: (2022)

HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms
por: Han, Bo-yue, et al.
Publicado: (2022)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Salvia chinensis Benth Inhibits Triple-Negative Breast Cancer Progression by Inducing the DNA Damage Pathway
por: Wang, Kai-nan, et al.
Publicado: (2022)

AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity
por: Wadhwa, Bhumika, et al.
Publicado: (2020)

SUN-131 The Roles of Two Insulin Receptor Isoforms in Triple Negative Breast Cancer Growth
por: Kang, Chifei, et al.
Publicado: (2020)

Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer
por: Zhou, Shu-Min, et al.
Publicado: (2015)

Functional inhibition of the RNA‐binding protein HuR sensitizes triple‐negative breast cancer to chemotherapy
por: Wei, Lanjing, et al.
Publicado: (2023)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Role of betulinic acid derivative SH-479 in triple negative breast cancer and bone microenvironment
por: Tang, Liang, et al.
Publicado: (2021)

Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
por: Tong, Ling, et al.
Publicado: (2023)

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
por: Luo, Chenyi, et al.
Publicado: (2022)

Colorectal Carcinogenesis: MSI-H Versus MSI-L
por: Pawlik, Timothy M., et al.
Publicado: (2004)

Knockdown of DNA/RNA-binding protein KIN17 promotes apoptosis of triple-negative breast cancer cells
por: Gao, Xiang, et al.
Publicado: (2019)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression
por: Yang, Xue, et al.
Publicado: (2022)

Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015)

MicroRNA-129-1-3p Represses the Progression of Triple-Negative Breast Cancer by Targeting the GRIN2D Gene
por: Li, Qi, et al.
Publicado: (2022)

Correlation between the Warburg effect and progression of triple-negative breast cancer
por: Liu, Shaojun, et al.
Publicado: (2023)

Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
por: Shu, Dan, et al.
Publicado: (2015)

MicroRNA‐493 is a prognostic factor in triple‐negative breast cancer
por: Yao, Ling, et al.
Publicado: (2018)

Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
por: Vella, Veronica, et al.
Publicado: (2021)

C/EBPβ isoform-specific regulation of migration and invasion in triple-negative breast cancer cells
por: Sterken, Britt A., et al.
Publicado: (2022)

Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer
por: Qin, Wenxing, et al.
Publicado: (2021)

MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
por: Ouyang, Mao, et al.
Publicado: (2014)

Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)

Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells
por: Löblein, Maria T., et al.
Publicado: (2021)

CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer
por: Yi, Baozhu, et al.
Publicado: (2022)

The Effects of Hedgehog on the RNA-Binding Protein Msi1 in the Proliferation and Apoptosis of Mesenchymal Stem Cells
por: Hong, In-Sun, et al.
Publicado: (2013)

Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression
por: Sha, Sha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0lcotp9p6a91h0k3s6ommn3kcv